NCT03575767View on ClinicalTrials.gov

Characteristics and Dynamics of TCR Repertoire in Patients With Hematological Malignancies After Allo-HSCT

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

May 8, 2018

Primary Completion Date

August 20, 2018

Study Completion Date

September 30, 2018

Conditions
Hematologic NeoplasmsHematopoietic Stem Cell TransplantationGraft Vs Host DiseaseRecurrence
Interventions
OTHER

Myeloablative Hematopoietic Stem Cell Transplantation

Myeloablative hematopoietic stem cell transplantation from many kinds of donors, including matched related donor, matched unrelated donor, haploidentical related donor.

Trial Locations (1)

100071

Affiliated Hospital to Academy of Military Medical Sciences, Beijing

All Listed Sponsors
collaborator

Hangzhou ImmuQuad Biotechnologies, LLC

UNKNOWN

lead

Affiliated Hospital to Academy of Military Medical Sciences

OTHER

NCT03575767 - Characteristics and Dynamics of TCR Repertoire in Patients With Hematological Malignancies After Allo-HSCT | Biotech Hunter | Biotech Hunter